Section: Press - posted in 2011

  • Caris Life Sciences and Miraca Holdings Complete Sale of Anatomic Pathology Business

    Inform Diagnostics Holdings Inc. (“Inform Diagnostics”), Japan’s largest clinical diagnostics and laboratory testing service provider, and Caris Life Sciences, Inc. (“CLS”), a privately-held company headquartered in Texas specializing in the development and commercialization of the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic ...
    Continue Reading
  • Caris Diagnostics Presents Research at 2011 Annual Meeting of the American College of Gastroenterology

    Company’s Research Efforts Include 15 Poster Presentations; Strong Presence in Key Areas of Colorectal Research Caris Diagnostics, a leading provider of expert anatomic pathology services, announced today upcoming highlights from the Company’s presentations at the American College of Gastroenterology (ACG) 2011 Annual Scientific Meeting being held in Washington, DC from October 29, ...
    Continue Reading
  • Olympus America Inc. and Caris Diagnostics Partner to Unveil New Pathology Reporting Tool

    Preferred partnership automates pathology for endoscopy providers, thereby enhancing diagnostic patient care. Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, and Caris Diagnostics, a leading provider of expert anatomic pathology services, have partnered to introduce a new automated pathology ...
    Continue Reading
  • Miraca Holdings to Acquire Caris Life Sciences’ Anatomic Pathology Business

    Inform Diagnostics Holdings Inc. (“Inform Diagnostics”), Japan’s largest clinical diagnostics and laboratory testing service provider, and Caris Life Sciences, Inc. (“CLS”), a privately-held company headquartered in Texas and specializing in the development and commercialization of the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic ...
    Continue Reading
  • Caris Life Sciences Presents Research Findings at Digestive Disease Week

    Data Presented in Two Podium Presentations and Five Posters Demonstrate Quality and Depth of Carispath™ Gastrointestinal (GI) Pathology Services Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, presented two podium ...
    Continue Reading
  • Caris Life Sciences Reports 2010 Highlights

    Leading Biosciences Company’s 2010 Performance Characterized by Cutting-Edge Technology Advancements and Significant Growth Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest-quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced key highlights of its 2010 ...
    Continue Reading
  • Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test

    Signal Genetics, the parent company of Myeloma Health LLC, a privately held predictive genetic testing company focused on oncology, and Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostic services, today announced a new agreement under which ...
    Continue Reading